Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DNASTAR Releases Lasergene 12 Software

Published: Thursday, June 19, 2014
Last Updated: Thursday, June 19, 2014
Bookmark and Share
Lasergene 12 improves sequence alignments and NGS accuracy.

DNASTAR® has announced the release of Lasergene 12, highlighting significant improvements in MegAlign Pro, a multiple sequence alignment application within Lasergene®, and industry-leading accuracy in NGS reference-guided assembly and SNP calling.

Additionally, the release features new, easy-to-use workflows designed for clinical researchers who analyze panels of genes, leveraging human exome or whole human genome data.

MegAlign Pro was initially released as part of Lasergene in the spring of 2013. Improvements to MegAlign Pro included in Lasergene 12 are the MAFFT alignment algorithm, several new analysis and visualization methods, and enhanced phylogenetic tree capability.

The Lasergene Genomics Suite has been dramatically improved in Lasergene 12, with SNP calling accuracy at 99.8% and the introduction of a series of new gene panel workflows. These enhancements will support clinical researchers by integrating VCF and BED (or Manifest) files for Mendelian/Germline and Cancer/Somatic investigations. The Lasergene Genomics Suite has also been enhanced to support SNP validation and control, which many clinical researchers find invaluable to their work.

Tom Schwei, Vice President and General Manager of DNASTAR, said, “DNASTAR has been delivering software to meet the needs in the molecular biology general research software market for the past 30 years. With Lasergene 12, we have continued to enhance our general research offering, while also putting a heavy emphasis on supporting the emerging needs of clinical researchers using Next-Generation Sequencing (NGS) data. The enhancements to MegAlign Pro and improved accuracy of our NGS assembler and SNP caller will serve all markets well, while the gene panel workflows are aimed at serving the clinical research market, which includes many of DNASTAR’s current customers. We are very pleased to continue to meet the needs of a wide range of molecular biologists and other life scientists. We look forward to continuing to broaden our appeal to researchers involved in genomics and related fields through future software releases and updates.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DNASTAR Appoints Biotech Del Norte Mexico as Distributor
Biotech del Norte distributes Company’s DNA, RNA and protein sequence analysis software in Mexico.
Wednesday, August 05, 2015
Wellcome Trust Sanger Institute Adopts DNASTAR Lasergene Software
Wellcome Trust Sanger Institute and DNASTAR have entered into a multi-year software license agreement.
Thursday, December 05, 2013
Dalhousie Medicine New Brunswick Adopts DNASTAR Lasergene Software
DMNB has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.
Thursday, September 05, 2013
DNASTAR Awarded Fast-Track Phase I and Phase II SBIR Grant
Company receives grant award from NIH to support the development of software for clinical research.
Wednesday, September 26, 2012
Scientific News
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Gene Behind Rare Childhood Syndrome Identified
Online activism by one patient’s mother spurred research collaboration which led to the identification of a new genetic syndrome.
Resilience Project Identifies Rare Unaffected Individuals
Researchers from Mount Sinai and Sage Bionetworks report analysis of nearly 600,000 genomes for resilience project.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Children With Cancer To Get New Gene Test
Pilot study will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment.
How The Bat Got Its Wings
Finding may provide clues to human limb development and malformations.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!